Drugs / ALPP CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06556108 | Jan 2018 → Jan 2025 | cancer | Xinqiao Hospital of Chongqing | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALPP CAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06556108 ↗ |
| Modality | Cell therapy | “CAR-T cells” NCT06556108 ↗ |
| Target | ALPP | “CAR targeting ALPP” NCT06556108 ↗ |